Patents by Inventor Hee-Ryong Kang

Hee-Ryong Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150115205
    Abstract: The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device comprising the same. Using the organic electroluminescent compound according to the present invention, it is possible to manufacture an OLED device of lowered driving voltages and advanced power efficiency.
    Type: Application
    Filed: May 2, 2013
    Publication date: April 30, 2015
    Applicant: ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD.
    Inventors: Hee-Ryong Kang, Bong-Ok Kim, Seung-Ae Kim, Yong-Gil Kim, Hyuck-Joo Kwon, Kyung-Joo Lee, Tae-Jin Lee, Jeong-Eun Yang
  • Publication number: 20140364625
    Abstract: The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device comprising the same. Using the organic electroluminescent compounds of the present invention as a phosphorescent host material, a hole transport material, and a mixed host material, it is possible to manufacture an OLED device with improved current efficiency.
    Type: Application
    Filed: January 16, 2013
    Publication date: December 11, 2014
    Inventors: Hee-Choon Ahn, Young-Gil Kim, Hee-Ryong Kang, Jeong-Eun Yang, Hyo-Nim Shin, Tae-Jin Lee, Young-Jun Cho, Kyung-Joo Lee, Hyuck-Joo Kwon, Bong-Ok Kim
  • Patent number: 8362267
    Abstract: Disclosed are a novel thiazole-containing benzophenone derivative represented by formula 1, and an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof and a solvate thereof, a pharmaceutical composition comprising the derivative, a use of the derivative as therapeutic agent and a method for preparing the derivative. The benzophenone thiazole derivatives inhibit formation of microtubules and eliminate actively proliferating cells of malignant tumors to control general cell proliferation. In formula 1, R, R1 and R2 are defined as above.
    Type: Grant
    Filed: March 5, 2009
    Date of Patent: January 29, 2013
    Assignee: Chong Kun Dang Pharmaceutical Corp.
    Inventors: Nam-Song Choi, Young-Hoon Kim, Jae-Kwang Lee, Hee-Ryong Kang, Ho-Jin Choi, Seung-Kee Moon, Soo-Jin Kim, Gyu-Tae Park, Byeong-Hoon Han, Dal-Hyun Kim, Jae-Hoon Choi, Sung-Sook Lee, Soon-Kil Ahn, Kyung-Joo Lee, Su-Yeal Bae
  • Publication number: 20110021582
    Abstract: Disclosed are a novel thiazole-containing benzophenone derivative represented by formula 1, and an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof and a solvate thereof, a pharmaceutical composition comprising the derivative, a use of the derivative as therapeutic agent and a method for preparing the derivative. The benzophenone thiazole derivatives inhibit formation of microtubules and eliminate actively proliferating cells of malignant tumors to control general cell proliferation. In formula 1, R, R1 and R2 are defined as above.
    Type: Application
    Filed: March 5, 2009
    Publication date: January 27, 2011
    Applicant: CHONG KUN DANG PHARMACEUTICAL CORP.
    Inventors: Nam-Song Choi, Young-Hoon Kim, Jae-Kwang Lee, Hee-Ryong Kang, Ho-Jin Choi, Seung-Kee Moon, Soo-Jin Kim, Gyu-Tae Park, Byeong-Hoon Han, Dal-Hyun Kim, Jae-Hoon Choi, Sung-Sook Lee, Soon-Kil Ahn, Kyung-Joo Lee, Su-Yeal Bae